Brain Stem Neoplasm clinical trials at UC Health
1 research study open to new patients
open to eligible people ages 12 months to 21 years
This phase I trial studies the side effects and best dose of entinostat in treating pediatric patients with solid tumors that have come back or have not responded to treatment. Entinostat may block some of the enzymes needed for cell division and it may help to kill tumor cells.